Scaling AI-Driven Discovery at Roche

28 Jan 2026
AI In Drug Discovery Stage
  • The accelerating advances in AI, generative models and computational biology. 

  • How investment in infrastructure, combining public and proprietary data, and team building is supporting AI implementation 

  • Data as the foundation - combining data sources, challenges around handling data 

  • Successes and lessons learned 

Speakers
Elif Ozkirimli
Elif Ozkirimli, Head of Computational Science Products - Roche